Treating prolactinomas with dopamine agonists: always worth the gamble?

@article{Noronha2015TreatingPW,
  title={Treating prolactinomas with dopamine agonists: always worth the gamble?},
  author={Sean Noronha and Victoria Stokes and Niki Karavitaki and Ashley Grossman},
  journal={Endocrine},
  year={2015},
  volume={51},
  pages={205-210}
}
Dopamine agonists are the treatment of choice for all patients with prolactinomas. They are generally safe, effective, and well-tolerated. However, a link between their use and the development of impulse control disorders has been well recognized in the field of neurology for some time, and evidence for a similar effect in endocrine patients is emerging. This has mainly been revealed through clinical case reports, plus a small number of comparative studies of varying robustness. We review the… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 38 references

Mattison, Reports of patholog- ical gambling, hypersexuality and compulsive shopping associ- ated with dopamine receptor agonist drugs

  • T. J. Moore, D.R.J. Glenmullen
  • JAMA Intern. Med
  • 2014
1 Excerpt

Development of impulse control disorders in patients with dopamine agonist - treated prolactinomas : a case series

  • T. B. Nippoldt
  • Clin . Neuropharmacol .
  • 2013

Similar Papers

Loading similar papers…